PreveCeutical MedicalFRA:18H0 +77.78% FCF Yield % is -19.23 as of Jul. 04, 2026. The stock has 3 warning signs investors should review. Among 1,413 Biotechnology companies, PreveCeutical Medical ranks worse than 65.89% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
PreveCeutical Medical FCF Yield % Related Terms
PreveCeutical Medical FCF Yield % Historical Data
* Premium members only.
The historical data trend for PreveCeutical Medical's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:18H0 vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, PreveCeutical Medical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PreveCeutical Medical FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's FCF Yield % distribution charts can be found below:
* The bar in red indicates where PreveCeutical Medical's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PreveCeutical Medical (FRA:18H0) has a FCF Yield % of -19.23 as of Jul. 04, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PreveCeutical Medical and its competitors. According to the industry distribution chart, PreveCeutical Medical ranks #931 out of 1413 companies in the Biotechnology industry, placing it in the top 65.9%.
Is PreveCeutical Medical's FCF Yield % too high?
PreveCeutical Medical's current FCF Yield % is -19.23. Based on the distribution chart, PreveCeutical Medical ranks #931 out of 1413 companies in the Biotechnology industry, which is below the industry midpoint.
How does PreveCeutical Medical's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PreveCeutical Medical ranks #931 out of 1413 companies for FCF Yield %. This places PreveCeutical Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PreveCeutical Medical and its competitors. PreveCeutical Medical's current FCF Yield % is -19.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PreveCeutical Medical stock overvalued right now?
PreveCeutical Medical (FRA:18H0) has a current FCF Yield % of -19.23. The current FCF Yield % is -19.23. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For PreveCeutical Medical (FRA:18H0), the current FCF Yield % is -19.23 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:18H0 has been successfully added to your 